Digoxin Tablet
Product Images NDC 0615-8202

2 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Digoxin (NDC 0615-8202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Digoxin-structural-from-usp-monograph-08-30-2023 (Digoxin Tabs 8202 1)

Digoxin-structural-from-usp-monograph-08-30-2023 (Digoxin Tabs 8202 1)
Chemical structure of digoxin showing its steroid nucleus with attached sugar moieties. The molecular diagram includes ring structures, hydroxyl groups, methyl groups, and a lactone ring characteristic of digoxin.*
FDA Label Image

Principal Display Panel (Digoxin Tabs 8202 2)

Principal Display Panel (Digoxin Tabs 8202 2)
This is a multi-panel label for Digoxin Tablets USP 125 mcg, oral tablets. The label shows the proprietary and generic name, product strength, quantity of 30 tablets, manufacturer information (West-Ward for Hikma, packaged by Vanguard), and multiple barcodes. It includes storage instructions and usage for institutional use only, with detailed barcode labels for individual tablet tracking.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.